Intracranial Pressure (Icp) Monitoring Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028

Intracranial Pressure Monitoring Devices Market Size 2024-2028

The intracranial pressure monitoring devices market size is estimated to grow by USD 632.4 million, at a CAGR of 6.78% between 2023 and 2028. Market growth hinges on multiple factors, notably an uptick in new product introductions, a surge in Mergers and Acquisitions (M&As), and the expanding applications of ICP monitoring devices. These elements are driving innovation and market expansion, leading to increased competitiveness and a broader range of offerings. Additionally, the growing adoption of these devices across various industries is enhancing their importance, further propelling market growth.  Furthermore, the market is witnessing increased investments in research and development, driving the creation of more advanced and specialized ICP monitoring devices. This trend is expected to fuel market growth by catering to a wider range of applications and improving the overall performance of these devices. Additionally, the strategic partnerships and collaborations between key players are enhancing market penetration and accelerating the adoption of ICP monitoring devices across different sectors.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, View Report Sample

Market Segmentation

By Product

The market share growth by the invasive segment will be significant during the forecast period. Invasive intracranial pressure (ICP) monitoring is performed by drilling a hole in the patient's skull and inserting a catheter into the brain tissue (the parenchyma) or into the ventricle (the space within the brain that contains the cerebrospinal fluid (CSF)). A sensor in the catheter continuously measures ICP. Implantation of a device to monitor ICP can be accomplished in three ways using intraventricular catheters, subdural screws, or epidural sensors. Of these methods,  intraventricular catheterization provides the most accurate results. 

Get a glance at the market contribution of various segments View the PDF Sample

The invasive segment was valued at USD 694.50 million in 2018. Invasive ICP monitoring is the traditional method. This is the gold standard and helps diagnose traumatic brain injury (TBI). The growth of this market segment is attributed to the increasing variety of products offered by companies in this category. Advances in technology have expanded the use of invasive ICP monitors in combination with other medical devices. For example, Integra LifeSciences offers the Camino Flex ventricular catheter in combination with Magnetic Resonance Imaging (MRI) scanning on 1.5 and 3 Tesla systems. The Camino Flex Ventricular Catheter is used for both ICP monitoring and CSF management. All these developments have led to the growth of the market segment. The market segment will continue to grow during the forecast period due to the wide range of invasive ICP surveillance devices available. 

By Region

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 45% to the growth of the market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. This is due to the presence of the United States and Canada, which contribute significantly to the revenue of the market. The presence of major global companies in the US is driving the market growth. Major companies such as Boston Neurosciences, Branchpoint Technologies, Integra LifeSciences, and Natus Medical are headquartered in the United States. The wide range of products offered by these companies will drive the growth of the regional market during the forecast period. 

Market Dynamics and Customer Landscape

The market is vital for managing conditions like Intracranial Aneurysms and intracranial hypertension therapy. Devices like Ophthalmoscopy and Pupillometry aid in monitoring Cranium Diameter and Cerebral Ventricles, ensuring optimal Brain Parenchyma health. Innovations such as non-invasive techniques and continuous ICP monitoring offer safer alternatives to Invasive methods, benefiting the growing Geriatric Population. With advancements in artificial intelligence and data analytics, these devices play a crucial role in Neuromonitoring and improving outcomes in various medical settings, including Space medical applications. 

Key Market Driver

Growing applications of intracranial pressure (ICP) monitoring devices are notably driving the market growth. Companies in the market are focusing on increasing surveillance applications. Previously, intracranial pressure monitoring devices were used to determine Traumatic brain injury (TBI). It is now widely used to monitor patients with brain tumors, stroke, and severe meningitis. In such cases, increased intracranial pressure, also known as intracranial hypertension, should be monitored continuously. This includes brain parenchyma, invasive methods, intracranial aneurysms, neuromonitoring, and external pressure transducer. Changes in intracranial pressure can cause life-threatening illnesses. In addition, if left untreated, it can damage the brain and spinal cord. In addition, brain tumors and strokes are common.

For example, according to the Centers for Disease Control and Prevention (CDC), approximately 795,000 people in the United States are affected by stroke each year. Furthermore, according to the NHS,  more than 9,000 people in the UK are diagnosed with brain tumors each year. With the increasing application of ICP monitoring and the increase in stroke and brain tumors, the use of ICP monitors is increasing. This will propel the growth of the market during the forecast period. 

Significant Market Trends

The rising advances in technology are a key trend influencing the Market growth. companies are developing innovative technologies to create next-generation products. For example, Branchpoint Technologies offers its FDA-approved AURA system for monitoring intracranial pressure. This is a fully implantable system with a wireless intracranial pressure sensor. A wireless intracranial pressure sensor enables mobile monitoring of intracranial pressure in brain injury patients. In contrast, traditional intracranial pressure monitoring systems require a cable connection to the patient's brain. The AURA system is completely wireless in terms of power supply and patient data transmission and is displayed directly on the bedside monitor.

In addition, continuous telemetry monitoring of parenchymal intracranial pressure is now possible, including continuous monitoring of intracranial pressure (ICP) waveform. These technological advances are helping doctors remotely monitor patients undergoing brain surgery. The presence of such next-generation products will boost sales of ICP monitors worldwide during the forecast period.  

Major Market Challenge

The complications associated with ICP monitoring devices are challenging the Market growth. The growth rate of the market is moderate. However, complications associated with the use of intracranial pressure monitoring systems hinder the market growth during the forecast period. Bleeding, brain herniation due to increased pressure, damage to brain tissue, postoperative wound infections, and the risks associated with the use of anesthetics are just a few of the complications that occur with intracranial pressure (ICP) monitors. Several devices are currently on the market for monitoring intracranial pressure. Monitoring of intracranial pressure can be done with an external ventricular drainage (EVD) device. In this technique, a catheter is surgically inserted into the ventricle. This allows cerebrospinal fluid (CSF) to be measured and drained. However, this technique is not suitable for patients with small ventricles or swollen brains.

Furthermore, long-term use of EVD can lead to intracranial infections. Intracranial hemorrhage is one of the potential complications of intracranial placement of invasive intracranial pressure monitoring devices. All of these complications can cause abnormalities and serious illnesses in affected individuals. These complications pose challenges to the growth of the market during the forecast period. 

Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Who are the Major Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Integra Lifesciences Holdings Corp: The company offers different types of intracranial pressure monitoring devices especially Licox Monitor, and ICP Express.

The report also includes detailed analyses of the competitive landscape of the market and information about 7 market companies, including:

• IRRAS AB
• Medtronic Plc
• Natus Medical Inc.
• Nisonic AS
• REHAU Group
• Spiegelberg GmbH and Co. KG
• Tokibo Co. Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Segment Overview

The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD million" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.

• Product Outlook 
  • Invasive
  • Non-invasive

• Application Outlook 
  • Traumatic brain injury
  • Intracerebral hemorrhage
  • Others

• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of World (ROW)
    • Australia
    • South Africa
    • Middle East

You may also interested in below market reports:

• Non-Invasive Intracranial Pressure Monitoring Devices Market by Application and Geography - Forecast and Analysis 
• Traumatic Brain Injury Assessment and Management Devices Market by End-user, Device and Geography - Forecast and Analysis
• US - Neurodiagnostic and Monitoring Devices Market by Product, End-user, and Application - Forecast and Analysis 

Market Analyst Overview

The market is essential for managing various conditions, including Subarachnoid Hemorrhage, Hydrocephalus, and Malignant Cerebral Infarction. Technologies like Otoacoustic Emission and Optic Nerve Sheath Diameter measurement, along with Neurodiagnostic solutions and Surgical microscopes, aid specialists in accurate diagnosis and treatment planning. Near-Infrared Spectroscopy and Computed Tomography play crucial roles in monitoring Cerebral Edema and CNS Infections. With advancements like telemedicine and continuous surveillance, healthcare providers can ensure timely intervention and reduce the risk of secondary brain damage.

In addition, the market is evolving with advanced technologies like Electroencephalography and Microtransducer ICP Monitoring to assess brain activity and intracranial pressure. Techniques such as Transcranial Doppler Ultrasonography aid in diagnosing conditions like Migraine and Obesity. Ambulatory Surgical Centers and Trauma Centers use these devices for critical care. Surgical advancements like 3D imaging and Surgical robots enhance precision in procedures. Ensuring real-time data and remote patient monitoring, along with early detection of issues like Infection and Malfunction, improves patient outcomes and drug administration in conditions like idiopathic intracranial hypertension.

View the PDF sample

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2024 and 2028
• Precise estimation of the size of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch